These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38064147)

  • 1. Correction to: Is it time for personalized therapy in IgA nephropathy patients?
    Schena FP; Cox SN
    J Nephrol; 2024 Jan; 37(1):257. PubMed ID: 38064147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of IgA nephropathy: Recent advances and prospects.
    Coppo R
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S13-S21. PubMed ID: 29606258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it time for personalized therapy in IgA nephropathy patients?
    Schena FP; Cox SN
    J Nephrol; 2023 Nov; 36(8):2171-2173. PubMed ID: 37737956
    [No Abstract]   [Full Text] [Related]  

  • 5. Fish oil therapy in IgA nephropathy.
    Fung SM; Ferrill MJ; Norton LL
    Ann Pharmacother; 1997 Jan; 31(1):112-5. PubMed ID: 8997477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early tonsillectomy for severe immunoglobulin A nephropathy significantly reduces proteinuria.
    Enya T; Miyazaki K; Miyazawa T; Oshima R; Morimoto Y; Okada M; Takemura T; Sugimoto K
    Pediatr Int; 2020 Sep; 62(9):1054-1057. PubMed ID: 32315477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of immunosuppressive therapy in patients with fibrinoid necrosis lesions in a large cohort of patients with IgA nephropathy.
    Guo Y; Shi S; Zhou X; Liu L; Lv J; Zhu L; Wang S; Zhang H
    J Nephrol; 2022 May; 35(4):1079-1089. PubMed ID: 34676523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tonsillectomy with methylprednisolone pulse therapy as rescue treatment for steroid-resistant IgA nephropathy in children.
    Kawasaki Y; Suyama K; Abe Y; Ushijima Y; Sakai N; Takano K; Ito M; Hashimoto K; Hosoya M
    Tohoku J Exp Med; 2009 May; 218(1):11-6. PubMed ID: 19398868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA Nephropathy in Elderly Patients.
    Sevillano AM; Diaz M; Caravaca-Fontán F; Barrios C; Bernis C; Cabrera J; Calviño J; Castillo L; Cobelo C; Delgado-Mallén P; Espinosa M; Fernandez-Juarez G; Fernandez-Reyes MJ; Garcia-Osuna R; Garcia P; Goicoechea M; Gonzalez-Cabrera F; Guzmán DA; Heras M; Martín-Reyes G; Martinez A; Olea T; Peña JK; Quintana LF; Rabasco C; López Revuelta K; Rodas L; Rodriguez-Mendiola N; Rodriguez E; San Miguel L; Sanchez de la Nieta MD; Shabaka A; Sierra M; Valera A; Velo M; Verde E; Ballarin J; Noboa O; Moreno JA; Gutiérrez E; Praga M;
    Clin J Am Soc Nephrol; 2019 Aug; 14(8):1183-1192. PubMed ID: 31311818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of patients with IgA nephropathy in Japan.
    Tomino Y
    Kidney Res Clin Pract; 2016 Dec; 35(4):197-203. PubMed ID: 27957413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategy with multidrug therapy and tonsillectomy pulse therapy for childhood-onset severe IgA nephropathy.
    Kawasaki Y
    Clin Exp Nephrol; 2022 Jun; 26(6):501-511. PubMed ID: 35119558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.
    Dillon JJ
    Semin Nephrol; 2004 May; 24(3):218-24. PubMed ID: 15156527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA nephropathy with crescents in kidney transplant recipients.
    Kowalewska J; Yuan S; Sustento-Reodica N; Nicosia RF; Smith KD; Davis CL; Alpers CE
    Am J Kidney Dis; 2005 Jan; 45(1):167-75. PubMed ID: 15696457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
    Zhang Q; Fan X; Tian M; Han H
    BMC Nephrol; 2020 Jul; 21(1):272. PubMed ID: 32660433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of a survey of the relationship between palatine tonsil and IgA nephropathy].
    Akagi H; Kosaka M; Doi A; Hattori K; Nishizaki K; Masuda Y
    Nihon Jibiinkoka Gakkai Kaiho; 1999 Mar; 102(3):305-10. PubMed ID: 10226466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights into the Pathogenesis of IgA Nephropathy.
    Novak J; Rizk D; Takahashi K; Zhang X; Bian Q; Ueda H; Ueda Y; Reily C; Lai LY; Hao C; Novak L; Huang ZQ; Renfrow MB; Suzuki H; Julian BA
    Kidney Dis (Basel); 2015 May; 1(1):8-18. PubMed ID: 26568951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in Pathogenesis of Immunoglobin A Nephropathy.
    Stanley JC; Deng H
    Cureus; 2020 Jun; 12(6):e8789. PubMed ID: 32724739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of IgA in pharyngeal washings from patients with IgA nephropathy.
    Tomino Y; Endoh M; Kaneshige H; Nomoto Y; Sakai H
    Am J Med Sci; 1983; 286(2):15-21. PubMed ID: 6614041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.